inh和pza在耐多药结核病中的药代动力学研究进展

S. Ramya, S. Shanmugam
{"title":"inh和pza在耐多药结核病中的药代动力学研究进展","authors":"S. Ramya, S. Shanmugam","doi":"10.32553/ijpba.v7i5.137","DOIUrl":null,"url":null,"abstract":"Tuberculosis remains a leading cause of morbidity and mortality in developing countries, including india. Isoniazid and pyrazinamide are powerful drugs administered as the First line and second line Anti-TB drugs in Tuberculosis affected patient. It plays a key role in shortening the TB therapy. Isoniazid (INH), and pyrazinamide (PZA) are the main drugs for the treatment of tuberculosis (TB). Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance (MDR) by not responding to the most powerful anti-TB agents. The complications of drug resistance in TB elevates the some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. Pharmacokinetics provides a basic time course of drugs and their effects in the body. These pharmacokinetic processes referred to as ADME. \nKey words Isoniazid, Pyrazinamide, MDR, ADME, TB","PeriodicalId":14229,"journal":{"name":"International Journal of Pharmaceutical and Biological Science Archive","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PHARMACOKINETICS OF INH AND PZA IN MDR-TB: A REVIEW\",\"authors\":\"S. Ramya, S. Shanmugam\",\"doi\":\"10.32553/ijpba.v7i5.137\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Tuberculosis remains a leading cause of morbidity and mortality in developing countries, including india. Isoniazid and pyrazinamide are powerful drugs administered as the First line and second line Anti-TB drugs in Tuberculosis affected patient. It plays a key role in shortening the TB therapy. Isoniazid (INH), and pyrazinamide (PZA) are the main drugs for the treatment of tuberculosis (TB). Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance (MDR) by not responding to the most powerful anti-TB agents. The complications of drug resistance in TB elevates the some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. Pharmacokinetics provides a basic time course of drugs and their effects in the body. These pharmacokinetic processes referred to as ADME. \\nKey words Isoniazid, Pyrazinamide, MDR, ADME, TB\",\"PeriodicalId\":14229,\"journal\":{\"name\":\"International Journal of Pharmaceutical and Biological Science Archive\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical and Biological Science Archive\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32553/ijpba.v7i5.137\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical and Biological Science Archive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32553/ijpba.v7i5.137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

结核病仍然是包括印度在内的发展中国家发病和死亡的主要原因。异烟肼和吡嗪酰胺是结核病患者一线和二线抗结核药物。它在缩短结核病治疗时间方面起着关键作用。异烟肼(INH)和吡嗪酰胺(PZA)是治疗结核病(TB)的主要药物。导致结核病的结核分枝杆菌可因对最有效的抗结核药物无反应而获得多重耐药性(MDR)。结核病耐药并发症增加了一些风险因素,如治疗依从性不足,患者不遵守治疗。药代动力学提供了药物及其在体内作用的基本时间过程。这些药代动力学过程称为ADME。关键词异烟肼,吡嗪酰胺,耐多药,ADME, TB
本文章由计算机程序翻译,如有差异,请以英文原文为准。
PHARMACOKINETICS OF INH AND PZA IN MDR-TB: A REVIEW
Tuberculosis remains a leading cause of morbidity and mortality in developing countries, including india. Isoniazid and pyrazinamide are powerful drugs administered as the First line and second line Anti-TB drugs in Tuberculosis affected patient. It plays a key role in shortening the TB therapy. Isoniazid (INH), and pyrazinamide (PZA) are the main drugs for the treatment of tuberculosis (TB). Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance (MDR) by not responding to the most powerful anti-TB agents. The complications of drug resistance in TB elevates the some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. Pharmacokinetics provides a basic time course of drugs and their effects in the body. These pharmacokinetic processes referred to as ADME. Key words Isoniazid, Pyrazinamide, MDR, ADME, TB
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信